PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
26-Sep-2024 Angle PLC Announces 100th Publication Supporting Parsortix System Use AccessWire
26-Sep-2024 Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies AccessWire
26-Sep-2024 Angle PLC Announces Half-year Report AccessWire
26-Sep-2024 Applied Science Releases New Advanced Technologies to Improve Care for People Living With Diabetes in Rural and Under-Served Communities AccessWire
25-Sep-2024 Coalition for Patient Rights (CPR) Urges Immediate Medical Cannabis Law Reform in Nevada with Broad Support from Integrative Healthcare AccessWire
25-Sep-2024 Prevail Partners and Prevail InfoWorks Enter Into Strategic Investment and Clinical Alliance With Kairos Pharma, Ltd. AccessWire
25-Sep-2024 Gruber Plastic Surgery Dispels Misconceptions on Awake Surgeries AccessWire
25-Sep-2024 Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference AccessWire
25-Sep-2024 Quasar Medical Acquires Ridgeback Technologies AccessWire
25-Sep-2024 SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders AccessWire
25-Sep-2024 Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands AccessWire
25-Sep-2024 Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US AccessWire
25-Sep-2024 GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis AccessWire
25-Sep-2024 Incredable(TM) (Formerly Ready Doc(R)) Launches New Provider App and Announces Attendance at NAMMS Conference AccessWire
25-Sep-2024 Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa AccessWire
25-Sep-2024 Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 AccessWire
25-Sep-2024 Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA AccessWire
25-Sep-2024 NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split AccessWire
25-Sep-2024 Explosive Growth in 3D Imaging Market Driven by Advancements in Healthcare and Industrial Applications Acumen Research And Consulting
25-Sep-2024 Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call AccessWire